Drug pricing

News

Santhera's DMD drug poised for wider rollout in Germany

Santhera has agreed pricing and reimbursement for its Duchenne muscular dystrophy drug Agamree with German health funds representing 90% of patients.

Market Access

NICE contribution to the cost per QALY threshold debate?

Leela Barham sets out some wider context to the latest blog from NICE on the cost-effectiveness threshold used by the agency and highlights the opportunity for stakeholders to build their c

R&D

Life Sciences Industry Report - Part 7 cover image

Life Sciences Industry Report - Biologics and Generics

The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.

News

Medicare price negotiations 'will continue under Trump'

President Trump will continue Medicare drug pricing negotiation but intends to look for improvements to the scheme according to CMS.

News

Robert F Kennedy Jr in the hot seat at the first confirmation hearing

Vaccines dominate questioning at RFK Jr's first hearing

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior anti-vaccine stance.

News

Lyfegen partners EVERSANA on pricing, access resource

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.

Santhera's DMD drug poised for wider rollout in Germany

NICE contribution to the cost per QALY threshold debate?

Life Sciences Industry Report - Biologics and Generics

Medicare price negotiations 'will continue under Trump'

Vaccines dominate questioning at RFK Jr's first hearing

Lyfegen partners EVERSANA on pricing, access resource

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Drug pricing

Editor's Picks